OK Biotech Co., Ltd. (TPE:4155)

OK Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	301.79	277.46	323.03	596.42	599.85	566.72
Trading Asset Securities	13.04	13.04	42.31	40.23	44.78	-
Cash & Short-Term Investments	314.83	290.5	365.34	636.64	644.64	566.72
Cash Growth	19.15%	-20.48%	-42.61%	-1.24%	13.75%	70.54%
Accounts Receivable	561.46	560.87	439.36	383.27	376.79	291.45
Other Receivables	27.27	27.62	49.23	26.21	28.11	14.69
Receivables	588.73	588.5	488.59	409.47	404.9	306.14
Inventory	530.27	530.54	394.05	422.95	375.64	349.07
Prepaid Expenses	67.49	62.35	64.47	49.47	57.76	53.33
Other Current Assets	1.49	0.79	4.91	7.98	6.06	0.31
Total Current Assets	1,503	1,473	1,317	1,527	1,489	1,276
Property, Plant & Equipment	1,743	1,627	865.71	874.73	659.4	606.04
Long-Term Investments	21.25	22.24	358.92	458.52	482.25	448.81
Goodwill	353.52	353.52	23.63	23.63	29.63	29.63
Other Intangible Assets	121.63	124.97	1.79	8.95	16.12	23.47
Long-Term Deferred Tax Assets	64.94	62.34	57.11	51.15	44.28	49.61
Other Long-Term Assets	11.06	32.39	442.84	117.71	92.09	101.92
Total Assets	3,818	3,695	3,067	3,061	2,813	2,535
Accounts Payable	207.25	258.32	203.8	244.63	240.4	207.56
Accrued Expenses	38.09	44.19	21.31	51.33	26.03	45.27
Short-Term Debt	335	305	155.03	185.73	187.04	172
Current Portion of Long-Term Debt	55.76	55.46	79.62	205.64	142.8	10.89
Current Portion of Leases	8	3.82	3.19	3.12	2.26	3.75
Current Income Taxes Payable	25.1	11.87	-	33.76	-	11.59
Current Unearned Revenue	58.69	48.44	90.32	67.83	53.87	40.15
Other Current Liabilities	59.36	17.67	24.86	36.14	48.16	162.2
Total Current Liabilities	787.23	744.76	578.13	828.18	700.55	653.42
Long-Term Debt	430.33	322	91.94	382.97	401.76	123.87
Long-Term Leases	19.4	33.77	2.17	3.17	-	3.8
Long-Term Deferred Tax Liabilities	27.91	27.85	-	0.43	-	-
Other Long-Term Liabilities	0.02	0.02	0.02	0.02	7.43	14.83
Total Liabilities	1,265	1,128	672.26	1,215	1,110	795.91
Common Stock	1,471	1,471	1,458	995.02	949.34	949.34
Additional Paid-In Capital	890.59	890.59	922.29	600.99	562.02	583.35
Retained Earnings	228.21	247.53	158.06	268.07	203.67	270.21
Treasury Stock	-	-	-	-	-	-33.92
Comprehensive Income & Other	-110.27	-116.64	-140.19	-19.46	-10.52	-40.38
Total Common Equity	2,479	2,492	2,398	1,845	1,705	1,729
Minority Interest	74.11	74.84	-2.76	1.79	-1.5	10.54
Shareholders' Equity	2,553	2,567	2,395	1,846	1,703	1,739
Total Liabilities & Equity	3,818	3,695	3,067	3,061	2,813	2,535
Total Debt	848.49	720.05	331.95	780.63	733.86	314.31
Net Cash (Debt)	-533.66	-429.55	33.39	-143.98	-89.22	252.41
Net Cash Per Share	-3.67	-2.93	0.26	-1.11	-0.75	2.53
Filing Date Shares Outstanding	147.06	143.06	145.77	109.66	104.63	103.21
Total Common Shares Outstanding	147.06	143.06	145.77	109.66	104.63	103.21
Working Capital	715.58	727.9	739.22	698.33	788.44	622.15
Book Value Per Share	16.86	17.42	16.45	16.82	16.29	16.75
Tangible Book Value	2,004	2,014	2,372	1,812	1,659	1,675
Tangible Book Value Per Share	13.63	14.08	16.28	16.52	15.85	16.23
Land	417.61	417.61	417.61	417.61	185.4	185.4
Buildings	345.47	345.47	345.04	344.72	343.3	340.7
Machinery	343.74	321.15	320.7	286.11	190.59	142.44
Construction In Progress	903.47	791.9	20.51	16.01	93.21	60.4

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.